Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.

Abstract:

OBJECTIVE:To investigate the long-term prognostic value of insulin-like growth factor-binding protein 1 in patients with acute myocardial infarction. METHODS:Patients ( n = 180) with admission glucose < 11 mmol/L without previously known diabetes admitted for an acute myocardial infarction in 1998-2000 were followed for mortality and cardiovascular events (first of cardiovascular mortality/acute myocardial infarction/stroke/severe heart failure) until the end of 2011 (median 11.6 years). Fasting levels of insulin-like growth factor-binding protein 1 at day 2 were related to outcome in Cox proportional hazard regression analyses. RESULTS:Median age was 64 years, 69% were male and median insulin-like growth factor-binding protein 1 was 20 µg/L. Total mortality was 34% ( n = 61) and 44% ( n = 80) experienced a cardiovascular event during a median follow-up time of 11.6 years. After age adjustment, insulin-like growth factor-binding protein 1 was associated with all-cause (1.40; 1.02-1.93, p = 0.039) and cancer mortality (2.09; 1.15-3.79, p = 0.015) but not with cardiovascular death ( p = 0.29) or cardiovascular events ( p = 0.57). After adjustments also for previous myocardial infarction, previous heart failure and body mass index, insulin-like growth factor-binding protein 1 was still associated with all-cause mortality (1.38; 1.01-1.89, p = 0.046). CONCLUSION:In patients with acute myocardial infarction without previously known diabetes, high insulin-like growth factor-binding protein 1 was associated with long-term all-cause and cancer mortality but not with cardiovascular events.

journal_name

Diab Vasc Dis Res

authors

Ritsinger V,Brismar K,Mellbin L,Näsman P,Rydén L,Söderberg S,Norhammar A

doi

10.1177/1479164118781892

subject

Has Abstract

pub_date

2018-09-01 00:00:00

pages

387-395

issue

5

eissn

1479-1641

issn

1752-8984

journal_volume

15

pub_type

杂志文章
  • Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.

    abstract::While few dispute the existence of the metabolic syndrome as a clustering of factors indicative of poor metabolic health, its utility above that of its individual components in the clinical care of individual patients is questioned. This is likely a consequence of the failure of clinicians and scientists to agree on a...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164119827611

    authors: Nolan CJ,Prentki M

    更新日期:2019-03-01 00:00:00

  • Interobserver reliability of the ankle-brachial index, toe-brachial index and distal pulse palpation in patients with diabetes.

    abstract:OBJECTIVE:We conducted a prospective pilot study in patients with diabetes to analyse the interobserver reliability of the ankle-brachial index, toe-brachial index and distal pulse palpation depending on the training of the professional involved. MATERIALS AND METHODS:The ankle-brachial index, toe-brachial index and d...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164118767599

    authors: Álvaro-Afonso FJ,García-Morales E,Molines-Barroso RJ,García-Álvarez Y,Sanz-Corbalán I,Lázaro-Martínez JL

    更新日期:2018-07-01 00:00:00

  • Holter monitoring for the screening of cardiac disease in diabetes mellitus: The non-invasive Holter monitoring observation of new cardiac events in diabetics study.

    abstract::We investigated the usefulness of Holter monitoring to detect cardiac disease and predict future cardiovascular risk in asymptomatic diabetic patients. This is a multi-centre, prospective study in 406 asymptomatic diabetic patients. They were categorized into three groups based on findings of Holter monitoring. A tota...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164115595523

    authors: Nakao YM,Ueshima K,Nohara R,Mizunuma Y,Segawa I,Tanaka-Mizuno S,Yasuno S,Nakao K,Hiramori K,Kihara Y

    更新日期:2015-11-01 00:00:00

  • Atherosclerosis in type 2 diabetes: a role for fibrate therapy?

    abstract::Vascular complications associated with type 2 diabetes confer significant morbidity and mortality. Atherosclerosis develops much earlier and progresses more rapidly than in subjects without diabetes. The clustering of cardiovascular risk factors associated with type 2 diabetes is mainly responsible for accelerated ath...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2007.067

    authors: Steiner G

    更新日期:2007-12-01 00:00:00

  • The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

    abstract::The objective of this study was to evaluate the safety and tolerability of atorvastatin 10 mg compared with placebo in 2,838 patients with type 2 diabetes and no history of coronary heart disease who were enrolled in the Collaborative Atorvastatin Diabetes Study (CARDS) and followed for 3.9 years. The percentages of p...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.3132/dvdr.2008.029

    authors: Newman CB,Szarek M,Colhoun HM,Betteridge DJ,Durrington PN,Hitman GA,Neil HA,Demicco DA,Auster S,Fuller JH,Cards Investigators.

    更新日期:2008-09-01 00:00:00

  • Lipid-altering efficacy of switching to ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk patients with and without metabolic syndrome.

    abstract::Metabolic syndrome (MetS) is a clustering of atherosclerotic coronary heart disease risk factors. This post-hoc analysis compared the effects of switching to ezetimibe/simvastatin 10/20 mg or rosuvastatin 10 mg in a cohort of 618 high-risk hypercholesterolaemic patients with (n=368) and without (n=217) MetS who had pr...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1177/1479164111418136

    authors: Averna M,Missault L,Vaverkova H,Farnier M,Viigimaa M,Dong Q,Shah A,Johnson-Levonas AO,Taggart W,Brudi P

    更新日期:2011-10-01 00:00:00

  • High prevalence of elevated haemoglobin A1C among adolescent blood donors: Results from a voluntary screening programme including 31,546 adolescents.

    abstract::More than 1 in 10 US adolescents have prediabetes or diabetes, and elevated glycosylated haemoglobin (HbA1C) in youth is associated with increased risk of death before the age of 55 years. We conducted a prospective, cross-sectional study of 31,546 consecutive volunteer blood donors, 16-19 years of age, who donated bl...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164115579799

    authors: Gore MO,Eason SJ,Ayers CR,Turer AT,Khera A,de Lemos JA,McGuire DK,Sayers M

    更新日期:2015-07-01 00:00:00

  • RAGE and its ligands: a lasting memory in diabetic complications?

    abstract::The complications of diabetes are myriad and represent a rising cause of morbidity and mortality, particularly in the Western world. The update of the Diabetes Control and Clinical Trials Group/Epidemiology of Diabetes Interventions and Complications Research Group (DCCT/EDIC) suggested that previous strict control of...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2004.001

    authors: Yan SF,Ramasamy R,Bucciarelli LG,Wendt T,Lee LK,Hudson BI,Stern DM,Lalla E,DU Yan S,Rong LL,Naka Y,Schmidt AM

    更新日期:2004-05-01 00:00:00

  • Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey.

    abstract:AIM:We examined eligibility and preventable cardiovascular disease events in US adults with diabetes mellitus from the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME). METHODS:We identified adults with diabetes mellitus eligible for EMPA-REG OUTCOME based on tri...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164120945674

    authors: Wong ND,Fan W,Pak J

    更新日期:2020-07-01 00:00:00

  • Skin microvascular function in patients with type 1 diabetes: An observational study from the onset of diabetes.

    abstract:BACKGROUND:The development of disturbances in skin microcirculation in type 1 diabetes is not well characterised. We assessed skin microcirculation longitudinally from the onset of diabetes up to 29 years of duration to investigate when such disturbances start. MATERIAL AND METHODS:Seventeen adult patients with type 1...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164117694463

    authors: Santesson P,Lins PE,Kalani M,Adamson U,Lelic I,von Wendt G,Fagrell B,Jörneskog G

    更新日期:2017-05-01 00:00:00

  • Respond to the letter on 'Interobserver reliability of the ankle brachial index, toe-brachial index and distal pulse palpation in patients with diabetes: a methodological issue'.

    abstract::We respond to the letter of Nadery and Shahsavari regarding our paper entitled 'Interobserver reliability of the ankle brachial index, toe -brachial index and distal pulse palpation in patients with diabetes. In this letter, we concluded that despite some limitations, the kappa coefficient is an informative measure of...

    journal_title:Diabetes & vascular disease research

    pub_type: 评论,信件

    doi:10.1177/1479164118794901

    authors: Álvaro Afonso FJ,García-Morales E,Molines-Barroso RJ,García-Álvarez Y,Sanz-Corbalán I,Lázaro-Martínez JL

    更新日期:2018-11-01 00:00:00

  • Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.

    abstract:OBJECTIVE:Statins are extensively used for lowering LDL-cholesterol and reducing cardiovascular events. Recent studies have shown that statins have beneficial anti-inflammatory effects. We aimed to determine whether and how adipokines are regulated during statin treatment in type 2 diabetic patients. METHOD:In this st...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164109339966

    authors: Hu Y,Tong G,Xu W,Pan J,Ryan K,Yang R,Shuldiner AR,Gong DW,Zhu D

    更新日期:2009-10-01 00:00:00

  • Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome.

    abstract:BACKGROUND AND OBJECTIVES:The risk of major adverse cardiac and cerebrovascular events following acute coronary syndrome is increased in people with diabetes. Predicting out-of-hospital outcomes upon follow-up remains difficult, and no simple, well-validated tools exist for this population at present. We aim to evaluat...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究

    doi:10.1177/1479164119892137

    authors: Baluja A,Rodríguez-Mañero M,Cordero A,Kreidieh B,Iglesias-Alvarez D,García-Acuña JM,Martínez-Gómez A,Agra-Bermejo R,Alvarez-Rodríguez L,Abou-Jokh C,López-Ratón M,Gude-Sampedro F,Alvarez-Escudero J,González-Juanatey JR

    更新日期:2020-01-01 00:00:00

  • Decade-long trends in the characteristics, management and hospital outcomes of diabetic patients with ST-segment elevation myocardial infarction.

    abstract:PURPOSE:Our objectives were to describe recent trends in the characteristics and in-hospital outcomes in diabetic as compared with non-diabetic patients hospitalized with ST-segment elevation myocardial infarction (STEMI). METHODS:We reviewed the medical records of 2537 persons with (n = 684) and without (n = 1853) a ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164114524235

    authors: Tisminetzky M,Joffe S,McManus DD,Darling C,Gore JM,Yarzebski J,Lessard D,Goldberg RJ

    更新日期:2014-05-01 00:00:00

  • Metabolic syndrome, aging, physical inactivity, and incidence of type 2 diabetes in general African population.

    abstract::The first objective of this study was to determine the baseline prevalence of metabolic syndrome and its individual components using the NCEP-R/ATPIII criteria, IDF criteria for Europe, and IDF criteria for Africa: waist circumference of at least 94 cm for men and women. The second objective was to investigate the inc...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164109346362

    authors: Longo-Mbenza B,On'kin JB,Okwe AN,Kabangu NK,Fuele SM

    更新日期:2010-01-01 00:00:00

  • Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

    abstract:OBJECTIVES:Assess the effect of risk factors changes on risk for cardiovascular disease and mortality in patients with type 2 diabetes selected from the Swedish National Diabetes Register. METHODS:Observational study of 13,477 females and males aged 30-75 years, with baseline HbA1c 41-67 mmol/mol, systolic blood press...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164116637311

    authors: Eeg-Olofsson K,Zethelius B,Gudbjörnsdottir S,Eliasson B,Svensson AM,Cederholm J

    更新日期:2016-07-01 00:00:00

  • Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.

    abstract:OBJECTIVE:To characterize copeptin levels and to explore its prognostic importance in patients with acute myocardial infarction with newly detected glucose abnormalities. METHODS:Copeptin was measured in 166 patients with acute myocardial infarction without known diabetes and in 168 age- and gender-matched controls. P...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究

    doi:10.1177/1479164116664490

    authors: Smaradottir MI,Ritsinger V,Gyberg V,Norhammar A,Näsman P,Mellbin LG

    更新日期:2017-03-01 00:00:00

  • Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention.

    abstract::There are few data concerning the relationship between diabetes mellitus, the metabolic syndrome and inflammation following elective percutaneous coronary intervention (PCI). The purpose of this study was to assess basal and peak levels of candidate cytokines in 40 patients undergoing elective PCI. Patients were categ...

    journal_title:Diabetes & vascular disease research

    pub_type: 临床试验,杂志文章

    doi:10.3132/dvdr.2005.003

    authors: Marso SP,Murphy JW,House JA,Safley DM,Harris WS

    更新日期:2005-02-01 00:00:00

  • Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.

    abstract::Guidelines recommend aggressive goals for lipid and blood pressure reduction for high risk patients with diabetes mellitus and atherosclerotic coronary disease. However, it remains unclear how many patients achieve treatment goals versus the number of people merely placed on treatment. We conducted an observational st...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164111431471

    authors: DeGuzman PB,Akosah KO,Simpson AG,Barbieri KE,Megginson GC,Goldberg RI,Beller GA

    更新日期:2012-04-01 00:00:00

  • Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?

    abstract:OBJECTIVE:The aim of this study was to determine whether high fitness attenuates the defects in left ventricular (LV) structure, function and triglyceride (TG) content in patients with type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS:Patients (n = 74) with T2DM and ≥1 additional cardiac risk factor were recruite...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164114540924

    authors: Sénéchal M,Ayers CR,Szczepaniak LS,Gore MO,See R,Abdullah SM,Berry JD,McGuire DK,McGavock JM

    更新日期:2014-09-01 00:00:00

  • Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

    abstract::Cardiovascular disease is the most common complication of type 2 diabetes mellitus (type 2 DM), accounting for approximately 80% of deaths. While atherosclerotic vascular disease accounts for much of the cardiovascular morbidity and mortality among diabetic patients, congestive heart failure (CHF) is another key compl...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2005.010

    authors: Patel C,Wyne KL,McGuire DK

    更新日期:2005-05-01 00:00:00

  • Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.

    abstract::We investigated the effect of atorvastatin monotherapy and combined treatment with atorvastatin and pioglitazone on intima-media thickness, vascular function and the cardiovascular risk profile. In all, 148 patients (76 male, 72 female; aged 61.4+/-6.5 years; body mass index [BMI] 29.2+/-4.1 kg/m2; mean +/- SD) with i...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.3132/dvdr.2008.043

    authors: Forst T,Wilhelm B,Pfützner A,Fuchs W,Lehmann U,Schaper F,Weber M,Müller J,Konrad T,Hanefeld M

    更新日期:2008-11-01 00:00:00

  • The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor.

    abstract::In order to discuss and establish a joint position on the treatment of low serum levels of high-density lipoprotein cholesterol (HDL-C), a group of experts involved in the care of people with dyslipidaemia and at risk of cardiovascular disease met in Miami, Florida, U.S., on 5th and 6th March 2005. The experts came fr...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,实务指引

    doi:10.3132/dvdr.2005.016

    authors: Espinosa-Larrañaga F,Vejar-Jalaf M,Medina-Santillán R,Latin American Group.

    更新日期:2005-10-01 00:00:00

  • Diabetes-induced early molecular and functional changes in aortic heart valves in a murine model of atherosclerosis.

    abstract::Diabetes contributes directly to the development of cardiovascular aortic valve disease. There is currently no drug therapy available for a dysfunctional valve and this urges the need for additional research to identify distinctive mechanisms of cardiovascular aortic valve disease evolution. The aim of this study was ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164119874469

    authors: Tucureanu MM,Filippi A,Alexandru N,Ana Constantinescu C,Ciortan L,Macarie R,Vadana M,Voicu G,Frunza S,Nistor D,Simionescu A,Simionescu DT,Georgescu A,Manduteanu I

    更新日期:2019-11-01 00:00:00

  • Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients.

    abstract:BACKGROUND:Musclin is a newly identified skeletal muscle-derived secretory factor, which has been recently characterized as a stimulator that induces insulin resistance in mice. However, the pathophysiological role of musclin in humans remains poorly understood. The aim of this study was to explore the potential correl...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164116675493

    authors: Chen WJ,Liu Y,Sui YB,Zhang B,Zhang XH,Yin XH

    更新日期:2017-03-01 00:00:00

  • Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.

    abstract:OBJECTIVES:Coronary atherosclerosis in patients with type 2 diabetes mellitus may be promoted by regional fat distribution. We investigated the association between anthropometric measures of obesity, truncal fat mass, epicardial adipose tissue and coronary atherosclerosis in asymptomatic patients and matched controls. ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164119825761

    authors: Gullaksen S,Funck KL,Laugesen E,Hansen TK,Dey D,Poulsen PL

    更新日期:2019-07-01 00:00:00

  • Association of central arterial stiffness with the presence and severity of diabetic retinopathy in Asians with type 2 diabetes.

    abstract:OBJECTIVE:Arterial stiffness has been associated with diabetic retinopathy; however, the information is limited in Asians. We aim to examine the association of central arterial stiffness with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients in Singapore. METHODS:Arterial stiffness...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164119845904

    authors: Zhang X,Lim SC,Tavintharan S,Yeoh LY,Sum CF,Ang K,Yeo D,Low S,Kumari N

    更新日期:2019-11-01 00:00:00

  • Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.

    abstract::Heart failure is now recognized as a progressive disease in which patients transition through the stages of being at risk of heart failure (stage A), to asymptomatic structural heart disease (stage B), to clinical manifestations of heart failure (stage C) and finally end-stage or refractory heart failure (stage D). Th...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164115579006

    authors: Lam CS

    更新日期:2015-07-01 00:00:00

  • Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.

    abstract::Glucose-lowering treatment options for type 2 diabetes mellitus patients with chronic kidney disease are limited. We evaluated the potential for linagliptin in combination with insulin in type 2 diabetes mellitus patients with mild-to-severe renal impairment. Data for participants in two phase 3 trials with linaglipti...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164115579001

    authors: McGill JB,Yki-Järvinen H,Crowe S,Woerle HJ,von Eynatten M

    更新日期:2015-07-01 00:00:00

  • Pancreatic-β-cell survival and proliferation are promoted by protein kinase G type Iα and downstream regulation of AKT/FOXO1.

    abstract::Early studies showed nitric oxide as a pro-inflammatory-cytokine-induced toxin involved in pancreatic β-cell destruction during pathogenesis of type-1 diabetes. However, nitric oxide has both cytotoxic and cytoprotective effects on mammalian cells, depending on concentration and micro-environmental surroundings. Our s...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164117713947

    authors: Wong JC,Vo V,Gorjala P,Fiscus RR

    更新日期:2017-09-01 00:00:00